Erkki Ruoslahti

Erkki Ruoslahti

Fondateur chez
Cend Therapeutics, Inc.

Fortune : 2 M $ au 31/08/2026

86 ans
Health Technology
Commercial Services
Consumer Services

Profil

Erkki Ruoslahti is the founder of Telios Pharmaceuticals, Inc. (founded in 1987), Targeted Molecules Corp.
(founded in 2000), and Cend Therapeutics, Inc. (founded in 2015).
He holds the title of Director at Telios Pharmaceuticals, Inc. from 1987 to 1995, Director at Targeted Molecules Corp.
from 2000 to 2002, and previously served as the Executive Chairman at Cend Therapeutics, Inc. Dr. Ruoslahti is also the founder of FIBRX Derm, Inc., Center For Nanomedicine, and Impilo Therapeutics, Inc. Dr. Ruoslahti's current job(s) include being a Professor at the University of California, Berkeley, a Member of the National Academy of Sciences, a Member of the American Academy of Arts & Sciences, a Member of the National Academy of Medicine (United States), and a Member of the European Molecular Biology Organization.
Dr. Ruoslahti's former job(s) include being the President & Chief Executive Officer of Sanford Burnham Prebys Medical Discovery Institute from 1976 to 2020, Director at Advance Technologies, Inc. from 2005 to 2008, Director at Canji, Inc. from 1993 to 1996, Independent Director at Astellas Institute for Regenerative Medicine from 2005 to 2011, Independent Director at Lisata Therapeutics, Inc. from 2022 to 2023, and Professor at the University of California, Santa Barbara from 2005 to 2015.
Dr. Ruoslahti obtained a doctorate degree from the University of Helsinki.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
17/04/2025 1 103 000 ( 12,24 % ) 2 M $ 31/08/2026

Postes actifs de Erkki Ruoslahti

SociétésPosteDébut
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal 01/07/2011
Fondateur 01/01/2015
European Molecular Biology Organization
Corporate Officer/Principal -

Anciens postes connus de Erkki Ruoslahti

SociétésPosteFin
LISATA THERAPEUTICS, INC. Directeur/Membre du Conseil 11/07/2023
Directeur Général 01/09/2020
Fondateur 01/09/2020
░░░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Erkki Ruoslahti

Formation de Erkki Ruoslahti

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

82

Relations au 1er degré

18

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées18

Health Technology

Electronic Technology

Commercial Services

Health Services

Consumer Services

Consumer Services

Health Technology

Consumer Services

Commercial Services

Commercial Services

Commercial Services

Health Services

European Molecular Biology Organization

Health Technology

Health Technology

Technology Services

Health Technology

Center For Nanomedicine

  1. Bourse
  2. Insiders
  3. Erkki Ruoslahti
-40% : Prolongation exceptionnelle ➤➤➤➤
j
:
:
PROFITEZ-EN MAINTENANT
🔇